Opus Genetics, Inc. IRD
NASDAQ · United States · Health Technology
$4.58+0.07 (+1.55%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.14 | -0.16 | +10.6% | $755.00K | -71.3% | -3.2%$3.78→$3.66 |
| Q1 2026 | 2026-05-12 | -0.75 | -0.14 | -435.7% | — | — | -1.8%$5.12→$5.03 |
| Q4 2025 | 2026-03-10 | -0.21 | -0.10 | -110.0% | — | — | +5.0%$4.77→$5.01 |
| Q3 2025 | 2025-11-12 | -0.25 | -0.13 | -92.3% | — | — | -6.1%$1.97→$1.85 |
| Q2 2025 | 2025-08-13 | -0.12 | -0.26 | +53.8% | — | — | — |
| Q1 2025 | 2025-05-15 | -0.24 | -0.20 | -20.0% | — | — | — |
| Q4 2024 | 2025-03-31 | -0.23 | -0.34 | +32.4% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.29 | -0.23 | -26.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.